ES2192885T3 - Metodo para evitar e inhibir la aterosclerosis en los mamiferos. - Google Patents
Metodo para evitar e inhibir la aterosclerosis en los mamiferos.Info
- Publication number
- ES2192885T3 ES2192885T3 ES99972104T ES99972104T ES2192885T3 ES 2192885 T3 ES2192885 T3 ES 2192885T3 ES 99972104 T ES99972104 T ES 99972104T ES 99972104 T ES99972104 T ES 99972104T ES 2192885 T3 ES2192885 T3 ES 2192885T3
- Authority
- ES
- Spain
- Prior art keywords
- aliquot
- mammal
- aterosclerosis
- mammals
- inhibit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0023—Agression treatment or altering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Electrotherapy Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
Utilización en la preparación de un medicamento para evitar la progresión de la aterosclerosis en un mamífero, de una muestra de la sangre de mamífero sometida extracorporalmente a una emisión electromagnética y un entorno oxidativo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19023698A | 1998-11-13 | 1998-11-13 | |
US09/304,262 US6264646B1 (en) | 1998-11-13 | 1999-05-06 | Method for preventing and reversing atherosclerosis in mammals |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2192885T3 true ES2192885T3 (es) | 2003-10-16 |
Family
ID=26885899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99972104T Expired - Lifetime ES2192885T3 (es) | 1998-11-13 | 1999-11-15 | Metodo para evitar e inhibir la aterosclerosis en los mamiferos. |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1128837B1 (es) |
JP (1) | JP2002529510A (es) |
CN (1) | CN1230182C (es) |
AT (1) | ATE233093T1 (es) |
AU (1) | AU768300B2 (es) |
BR (1) | BR9915270A (es) |
CA (1) | CA2348599A1 (es) |
CZ (1) | CZ20011642A3 (es) |
DE (1) | DE69905602T2 (es) |
DK (1) | DK1128837T3 (es) |
EA (1) | EA003421B1 (es) |
ES (1) | ES2192885T3 (es) |
MX (1) | MXPA01004801A (es) |
NO (1) | NO20012311L (es) |
NZ (1) | NZ511467A (es) |
WO (1) | WO2000029003A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2271190A1 (en) * | 1999-05-06 | 2000-11-06 | Vasogen Ireland Limited | Improved method for treating mammals with modified mammalian blood |
JP2003510284A (ja) * | 1999-09-24 | 2003-03-18 | バソジェン アイルランド リミテッド | アテローム性動脈硬化症の処置のための併用療法 |
CA2309417A1 (en) | 2000-05-25 | 2001-11-25 | Anthony E. Bolton | Apoptotic entities for use in treatment of endothelium dysfunction disorders |
WO2005097145A1 (en) * | 2004-04-12 | 2005-10-20 | Vasogen Ireland Limited | Myocarditis treatment |
WO2008000067A1 (en) * | 2006-06-26 | 2008-01-03 | Vasogen Ireland Limited | Treatment of mild chronic heart failure in human patients |
RU2475275C1 (ru) * | 2011-08-08 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения облитерирующего атеросклероза артерий нижних конечностей |
RU2475274C1 (ru) * | 2011-08-09 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения атеросклероза артерий нижних конечностей |
RU2475276C1 (ru) * | 2011-08-09 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения облитерирующего атеросклероза артерий нижних конечностей |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD249143A3 (de) * | 1985-03-20 | 1987-09-02 | Ilmenau Tech Hochschule | Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes |
US5980954A (en) * | 1992-02-07 | 1999-11-09 | Vasogen Ireland Limited | Treatment of autoimmune diseases |
WO1993015778A1 (en) * | 1992-02-07 | 1993-08-19 | Anthony Ernest Bolton | Method of inhibiting the aggregation of blood platelets |
-
1999
- 1999-11-15 CZ CZ20011642A patent/CZ20011642A3/cs unknown
- 1999-11-15 ES ES99972104T patent/ES2192885T3/es not_active Expired - Lifetime
- 1999-11-15 EA EA200100543A patent/EA003421B1/ru not_active IP Right Cessation
- 1999-11-15 AU AU11450/00A patent/AU768300B2/en not_active Ceased
- 1999-11-15 CN CNB998146390A patent/CN1230182C/zh not_active Expired - Fee Related
- 1999-11-15 DE DE69905602T patent/DE69905602T2/de not_active Expired - Lifetime
- 1999-11-15 NZ NZ511467A patent/NZ511467A/xx not_active IP Right Cessation
- 1999-11-15 JP JP2000582049A patent/JP2002529510A/ja not_active Withdrawn
- 1999-11-15 DK DK99972104T patent/DK1128837T3/da active
- 1999-11-15 BR BR9915270-3A patent/BR9915270A/pt not_active Application Discontinuation
- 1999-11-15 MX MXPA01004801A patent/MXPA01004801A/es not_active IP Right Cessation
- 1999-11-15 CA CA002348599A patent/CA2348599A1/en not_active Abandoned
- 1999-11-15 WO PCT/CA1999/001092 patent/WO2000029003A2/en active IP Right Grant
- 1999-11-15 AT AT99972104T patent/ATE233093T1/de not_active IP Right Cessation
- 1999-11-15 EP EP99972104A patent/EP1128837B1/en not_active Expired - Lifetime
-
2001
- 2001-05-10 NO NO20012311A patent/NO20012311L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000029003A3 (en) | 2000-08-31 |
DK1128837T3 (da) | 2003-06-16 |
DE69905602D1 (de) | 2003-04-03 |
ATE233093T1 (de) | 2003-03-15 |
CN1230182C (zh) | 2005-12-07 |
DE69905602T2 (de) | 2003-10-09 |
CZ20011642A3 (cs) | 2002-06-12 |
AU768300B2 (en) | 2003-12-04 |
CN1330549A (zh) | 2002-01-09 |
MXPA01004801A (es) | 2002-09-18 |
JP2002529510A (ja) | 2002-09-10 |
EP1128837A2 (en) | 2001-09-05 |
EA003421B1 (ru) | 2003-04-24 |
EA200100543A1 (ru) | 2001-10-22 |
BR9915270A (pt) | 2003-12-30 |
NZ511467A (en) | 2002-12-20 |
NO20012311D0 (no) | 2001-05-10 |
AU1145000A (en) | 2000-06-05 |
WO2000029003A2 (en) | 2000-05-25 |
NO20012311L (no) | 2001-07-02 |
EP1128837B1 (en) | 2003-02-26 |
CA2348599A1 (en) | 2000-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE288749T1 (de) | Verwendung von kannabidiol als entzündunghemmende mittel | |
EA199800667A1 (ru) | Новые фенантридины | |
ES2192642T3 (es) | Producto para el teñido oxidante de fibras de queratina.. | |
EA200200097A1 (ru) | Имидазоимидазолы и триазолы в качестве противовоспалительных агентов | |
EA200000251A1 (ru) | Производные резорцинола | |
CA2400801A1 (en) | Treatment of congestive heart failure by pretreated autologous blood | |
ES2159309T3 (es) | Semillas tratadas. | |
EA200100571A1 (ru) | Комбинированный способ лечебного воздействия, включающий применение лучевой терапии и ингибитора циклооксигеназы-2(cox-2) для лечения неоплазии | |
EA199900421A1 (ru) | Бензонафтиридины в качестве бронхиальных терапевтических средств | |
ES2192885T3 (es) | Metodo para evitar e inhibir la aterosclerosis en los mamiferos. | |
ATE109459T1 (de) | Cyclopropylderivate als lipoxygenase-inhibitoren. | |
AR022583A1 (es) | Secuencias antitumorales anti-sentido dirigidas contra los componentes r1 y r2 de la reductasa de los ribonucleotidos | |
ES2167678T3 (es) | Tratamiento y profilaxis de la pancreatitis. | |
ES2102403T3 (es) | Metodo para endurecer rodillos de ondular. | |
DK0910365T3 (da) | Væksthæmning og udslettelse af faste tumorer ved at anvende en prolactinmodulator og en fotosensibilisator | |
ES2187799T3 (es) | Complejos de bis-platino con derivados de polimetileno como ligandos que tienen actividad antitumoral. | |
DE60330051D1 (de) | Ittels mikrowellenbestrahlung | |
SE9803079L (sv) | Sätt och anordning vid värmebehandling av kroppsvävnad | |
ES2158441T3 (es) | Arilheterociclos con actividad herbicida. | |
EA199900174A1 (ru) | Способ лечения биполярного расстройства | |
EA199800058A1 (ru) | Способ лечения доброкачественной гиперплазии предстательной железы, лекарственная форма для лечения доброкачественной гиперплазии, содержащая агонист мелатонина | |
PT1017377E (pt) | Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina | |
ECSP961804A (es) | Nuevos compuestos monociclicos de b -.lactama | |
ES1027841Y (es) | Puya perfeccionada para picar toros. | |
GB2299335A (en) | Hydroxamic acid derivatives as metalloproteinase inhibitors |